ArticleActa Cardiologica Sinica2025

Efficacy, Safety, Cost, and Clinical Outcomes after the Switch to Generic Rosuvastatin Compared with Consistent Brand-Name Atorvastatin Treatment.

Mu-Shiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.